Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nordlander

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Biochimica Et Biophysica Acta|March 24, 1993
The effect of felodipine on the uptake and degradation of acetylated LDL in mouse peritoneal cells and on the distribution of acetylated LDL in macrophage-rich organs of the ratS Gustafson, A Menschik-Lundin, M Nordlander, et al.
European Journal of Pharmacology|July 11, 1985
Renal and cardiovascular effects of acute and chronic administration of felodipine to SHRM Nordlander, G F Di Bona, B Ljung, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 30, 1999
Pharmacokinetics of new calcium channel antagonist clevidipine in the rat, rabbit, and dog and pharmacokinetic/pharmacodynamic relationship in anesthetized dogsH Ericsson, B Tholander, J A Björkman, et al.
Acta Physiologica Scandinavica|March 1, 1992
Trophic effects of hypophyseal hormones on resistance vessels and the heart in normotensive and renal hypertensive ratsB Folkow, O G Isaksson, G Karlström, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1988
The importance of hypophyseal hormones for structural cardiovascular adaptation in hypertensionB Folkow, O P Isaksson, G Karlström, et al.
European Journal of Pharmacology|May 4, 2001
Pharmacology of H 394/84, a dihydropyridine neuropeptide Y Y(1) receptor antagonist, in vivoR E Malmström, K C Balmér, J Weilitz, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1994
Comparison of effects of dihydropyridine calcium antagonists on left ventricular systolic and diastolic performanceC P Cheng, T Noda, M Nordlander, et al.
European Heart Journal|October 1, 1993
Coronary venous retroinfusion of felodipine reducing infarct size without affecting regional myocardial blood flowY Haga, N Hatori, M Nordlander, et al.
Journal of Cardiovascular Pharmacology|September 7, 2000
Calcium antagonist protects the myocardium from reperfusion injury by interfering with mechanisms directly related to reperfusion: an experimental study with the ultrashort-acting calcium antagonist clevidipineD Segawa, P O Sjöquist, Q D Wang, et al.
Anesthesiology|February 7, 2001
Pharmacokinetics and arteriovenous differences in clevidipine concentration following a short- and a long-term intravenous infusion in healthy volunteersH Ericsson, U Bredberg, U Eriksson, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Biochimica Et Biophysica Acta|March 24, 1993
The effect of felodipine on the uptake and degradation of acetylated LDL in mouse peritoneal cells and on the distribution of acetylated LDL in macrophage-rich organs of the ratS Gustafson, A Menschik-Lundin, M Nordlander, et al.
European Journal of Pharmacology|July 11, 1985
Renal and cardiovascular effects of acute and chronic administration of felodipine to SHRM Nordlander, G F Di Bona, B Ljung, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 30, 1999
Pharmacokinetics of new calcium channel antagonist clevidipine in the rat, rabbit, and dog and pharmacokinetic/pharmacodynamic relationship in anesthetized dogsH Ericsson, B Tholander, J A Björkman, et al.
Acta Physiologica Scandinavica|March 1, 1992
Trophic effects of hypophyseal hormones on resistance vessels and the heart in normotensive and renal hypertensive ratsB Folkow, O G Isaksson, G Karlström, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1988
The importance of hypophyseal hormones for structural cardiovascular adaptation in hypertensionB Folkow, O P Isaksson, G Karlström, et al.
European Journal of Pharmacology|May 4, 2001
Pharmacology of H 394/84, a dihydropyridine neuropeptide Y Y(1) receptor antagonist, in vivoR E Malmström, K C Balmér, J Weilitz, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1994
Comparison of effects of dihydropyridine calcium antagonists on left ventricular systolic and diastolic performanceC P Cheng, T Noda, M Nordlander, et al.
European Heart Journal|October 1, 1993
Coronary venous retroinfusion of felodipine reducing infarct size without affecting regional myocardial blood flowY Haga, N Hatori, M Nordlander, et al.
Journal of Cardiovascular Pharmacology|September 7, 2000
Calcium antagonist protects the myocardium from reperfusion injury by interfering with mechanisms directly related to reperfusion: an experimental study with the ultrashort-acting calcium antagonist clevidipineD Segawa, P O Sjöquist, Q D Wang, et al.
Anesthesiology|February 7, 2001
Pharmacokinetics and arteriovenous differences in clevidipine concentration following a short- and a long-term intravenous infusion in healthy volunteersH Ericsson, U Bredberg, U Eriksson, et al.
Pageof 6